[A case of toxic shock syndrome (TSS) confirmed by demonstration of toxic shock syndrome toxin-1 (TSST-1) in the serum]. 1988

J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001427 Bacterial Toxins Toxic substances formed in or elaborated by bacteria; they are usually proteins with high molecular weight and antigenicity; some are used as antibiotics and some to skin test for the presence of or susceptibility to certain diseases. Bacterial Toxin,Toxins, Bacterial,Toxin, Bacterial
D012772 Shock, Septic Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. Endotoxin Shock,Septic Shock,Shock, Endotoxic,Shock, Toxic,Toxic Shock,Toxic Shock Syndrome,Endotoxin Shocks,Shock Syndrome, Toxic,Shock, Endotoxin,Shocks, Endotoxin,Toxic Shock Syndromes
D018089 Superantigens Microbial antigens that have in common an extremely potent activating effect on T-cells that bear a specific variable region. Superantigens cross-link the variable region with class II MHC proteins regardless of the peptide binding in the T-cell receptor's pocket. The result is a transient expansion and subsequent death and anergy of the T-cells with the appropriate variable regions. Superantigen

Related Publications

J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
January 1988, Methods in enzymology,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
January 1989, European journal of pediatrics,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
August 1987, Journal of medical microbiology,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
June 1988, Clinical and investigative medicine. Medecine clinique et experimentale,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
January 1989, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
August 2010, Burns : journal of the International Society for Burn Injuries,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
September 1999, Burns : journal of the International Society for Burn Injuries,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
June 1985, The Journal of infectious diseases,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
June 1987, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
J Mihara, and T Asakura, and M Moriuchi, and H Kojima, and M Maki, and S Saitoh, and T Shiratsuti, and H Igarashi
August 1991, Letters in applied microbiology,
Copied contents to your clipboard!